Obuhangire bwa Viatris (VTRS) bwa Sikaati
Viatris
AI forecast: VTRS
AI ebandika ekiruho ky'obusobozi bw'omubere gw'ekiseera ekiddako, ekigero ky'omubere gw'ebirungi, n'ekigero ky'omubere gw'omwezi. Okuhinduka kuhakirizwa hakurikira obusobozi bwa nyuma. Bino ni obuhangire bw'obusobozi, si obuhangire bw'okuhanga.
Ebiharwa by'omwaka guhera mu myezi 6 eyita
Premium erikahyora ebyifujiraho by'AI eby'omutengo mu nsi y'omunzi omu, wiiki emu n'omwaka omu ku kizigirwa kino n'ebirala byonna.
Unlock Premium🔒 Ekihugho ky'obuhangire bw'obusobozi
Ekihugho ky'obuhangire bw'obusobozi — buli kihuugho ky'omubere gya nyuma hafi n'obusobozi bwa nyakuri — ni ekigero cya Premium.
Unlock PremiumEbikwata ku Kitongole Kino
On November 16, 2020, Viatris Inc. was formed through the successful merger of Mylan N.V. and Pfizer’s Upjohn business unit. Leveraging the heritage of these two complementary businesses, Viatris possesses scientific, manufacturing, and logistics infrastructure, as well as significant expertise in regulatory, medical, and commercial matters, enabling it to provide patients with quality medicines in more than 165 countries.
